The Institute for Clinical and Economic Review has prepared a special report on Trelegy and Breo, two therapies that treat ...

The current model for managing chronic obstructive pulmonary disease (COPD) generally considers inhalers from the same therapeutic class to be clinically equivalent.1 When a long-acting muscarinic ...

Professor David Denning evaluates timely and accurate diagnosis of Aspergillus infection and the clinical spectrum of ...

Medically reviewed by Susan Russell, MD The term "smoker's lung" refers to lung damage caused by smoking cigarettes. Over ...

Vantage Market Research is pleased to announce the publication of its latest report, Asthma and COPD Drugs Market. This ...

What should you know about RSV and who can get it? In many cases, there is a difference for adults and children, ...

Many Part D prescription drug plans cover Trelegy Ellipta, but costs can vary by plan type and insurer. Read more.

Researchers at the La Jolla Institute for Immunology (LJI) have developed a specific drug "cocktail" that promises to curb severe asthma flare-ups, potentially decreasing the reliance on inhalers ...

The world is witnessing an entirely different America. The resulting sights and sounds that assault our senses engender scorn and hatred. The US has dramatically lost copious amounts of goodwill. All ...

"This is important, because right now, inhaled pharmaceuticals are designed with a one-size-fits-all approach. But someone who has severe COPD, for example, is going to breathe very differently and ...

Patients with COPD had better inhaler adherence when invited to enroll in a program that lowers cost sharing for maintenance inhalers and offers medication management services, according to results ...